Keiichi Fukuda

Company: Heartseed Inc

Job title: Chief Executive Officer

Seminars:

New Era of Heart Failure Treatment: Regenerative Cell Therapy Using Ventricular Specific Purified Cardiomyocytes 9:00 am

Scalable method to eliminate undifferentiated iPSCs by difference of metabolism between iPSCs and cardiomyocytes Clinical data from FIH study of purified cardiomyocyte spheroids Platform technology to develop high quality iPSC-derived productRead more

day: Conference Day Two